Repros Therapeutics Q1 Loss Narrows

(RTTNews) - Repros Therapeutics Inc. (RPRX) Monday said first-quarter loss narrowed to $8.5 million or $0.37 per share from $7.4 million or $0.41 per share in the same period last year.

On average, six analysts polled by Thomson Reuters expected the company to report a loss of $0.35 per share for the quarter. Analysts' estimates typically exclude special items.

Revenues and other income increased to $2 thousand from $1 thousand last year.

Research and development expenses increased 16 percent to $7.3 million from $6.3 million last year. General and administrative totaled $1.2 million, up 15 percent from $1.1 million.